Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.43K Buy
53
+36
+212% +$2.89K ﹤0.01% 301
2026
Q1
$1.42K Hold
17
﹤0.01% 320
2025
Q4
$1.14K Hold
17
﹤0.01% 335
2025
Q3
$1.15K Hold
17
﹤0.01% 322
2025
Q2
$1.27K Buy
17
+16
+1,600% +$1.07K ﹤0.01% 331
2025
Q1
$995 Sell
1
-16
-94% -$989 ﹤0.01% 347
2024
Q4
$953 Hold
17
﹤0.01% 366
2024
Q3
$994 Hold
17
﹤0.01% 366
2024
Q2
$914 Buy
+17
New +$936 ﹤0.01% 327

Other funds holding CTVA

BNP Paribas's CTVA Position: Q2 2026 in Review

BNP Paribas increased its Corteva (CTVA) stake by 212% in Q2 2026, buying an estimated $2.89K and bringing the position to 53 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

BNP Paribas first reported a position in CTVA in Q2 2024 and has held it in 9 quarters since. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • BNP Paribas held 53 shares of Corteva worth $4.43K as of Q2 2026.
  • BNP Paribas bought 36 Corteva shares in Q2 2026, an estimated $2.89K.
  • Corteva made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #301 holding.
  • BNP Paribas first reported a position in Corteva in Q2 2024 and has held it in 9 quarters since.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.